{
  "trial_id": "NCT02497443",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Clinical diagnosis of symptomatic epilepsy",
      "label": "met"
    },
    {
      "criterion": "Disease progression for the last 1-3 years",
      "label": "met"
    },
    {
      "criterion": "Resistance of epilepsy to therapy with carbamazepine, valproic acid, topiramate, lamotrigine, and phenobarbital (anti-epileptic drugs/AEDs) as monotherapies or combination therapies",
      "label": "met"
    },
    {
      "criterion": "Signed informed consent",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "CNS inflammatory conditions, chronic psychoses, CNS tumors, relapses of chronic somatic or neurologic diseases, and blood positivity for hepatitis B or C or HIV",
      "label": "triggers"
    }
  ],
  "notes": "Patient has a history of severe intellectual disability, CHF, epilepsy, and has been experiencing seizures. They have not responded well to previous treatments.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT02497443",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}